A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

New targeted drugs transform HER2, ROS1 and ALK lung cancer care, boosting brain response and survival—while precision choices still matter.

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their ...

This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...

A research team has discovered a crucial mechanism that underlies chemotherapy resistance and metastasis in small cell lung ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

Lung cancer in never smokers is an increasingly recognized global health issue with distinct biological drivers, ...